Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
1983 1
1984 1
1985 2
1986 1
1987 2
1988 1
1989 7
1990 5
1991 7
1992 3
1993 6
1994 7
1995 8
1996 15
1997 7
1998 6
1999 2
2000 9
2001 4
2002 4
2003 5
2004 6
2005 6
2006 4
2007 10
2008 7
2009 5
2010 9
2011 6
2012 2
2013 5
2014 1
2015 2
2016 1
2017 2
2018 1
2019 2
2020 1
2021 3
2022 1
2023 2
2024 1

Text availability

Article attribute

Article type

Publication date

Search Results

173 results

Results by year

Filters applied: . Clear all
Page 1
Phase I/II trial of a peptide-based COVID-19 T-cell activator in patients with B-cell deficiency.
Heitmann JS, Tandler C, Marconato M, Nelde A, Habibzada T, Rittig SM, Tegeler CM, Maringer Y, Jaeger SU, Denk M, Richter M, Oezbek MT, Wiesmüller KH, Bauer J, Rieth J, Wacker M, Schroeder SM, Hoenisch Gravel N, Scheid J, Märklin M, Henrich A, Klimovich B, Clar KL, Lutz M, Holzmayer S, Hörber S, Peter A, Meisner C, Fischer I, Löffler MW, Peuker CA, Habringer S, Goetze TO, Jäger E, Rammensee HG, Salih HR, Walz JS. Heitmann JS, et al. Among authors: wiesmuller kh. Nat Commun. 2023 Aug 18;14(1):5032. doi: 10.1038/s41467-023-40758-0. Nat Commun. 2023. PMID: 37596280 Free PMC article. Clinical Trial.
Mimotope vaccines for cancer immunotherapy.
Sharav T, Wiesmüller KH, Walden P. Sharav T, et al. Among authors: wiesmuller kh. Vaccine. 2007 Apr 20;25(16):3032-7. doi: 10.1016/j.vaccine.2007.01.033. Epub 2007 Jan 22. Vaccine. 2007. PMID: 17276556 Review.
NANOCI-Nanotechnology Based Cochlear Implant With Gapless Interface to Auditory Neurons.
Senn P, Roccio M, Hahnewald S, Frick C, Kwiatkowska M, Ishikawa M, Bako P, Li H, Edin F, Liu W, Rask-Andersen H, Pyykkö I, Zou J, Mannerström M, Keppner H, Homsy A, Laux E, Llera M, Lellouche JP, Ostrovsky S, Banin E, Gedanken A, Perkas N, Wank U, Wiesmüller KH, Mistrík P, Benav H, Garnham C, Jolly C, Gander F, Ulrich P, Müller M, Löwenheim H. Senn P, et al. Among authors: wiesmuller kh. Otol Neurotol. 2017 Sep;38(8):e224-e231. doi: 10.1097/MAO.0000000000001439. Otol Neurotol. 2017. PMID: 28806330 Free PMC article. Review.
Quantitative analysis of peptide-MHC class II interaction.
Fleckenstein B, Jung G, Wiesmüller KH. Fleckenstein B, et al. Among authors: wiesmuller kh. Semin Immunol. 1999 Dec;11(6):405-16. doi: 10.1006/smim.1999.0198. Semin Immunol. 1999. PMID: 10625594 Review.
Long-term efficacy of the peptide-based COVID-19 T cell activator CoVac-1 in healthy adults.
Tandler C, Heitmann JS, Michel TM, Marconato M, Jaeger SU, Tegeler CM, Denk M, Richter M, Oezbek MT, Maringer Y, Schroeder SM, Schneiderhan-Marra N, Wiesmüller KH, Bitzer M, Ruetalo N, Schindler M, Meisner C, Fischer I, Rammensee HG, Salih HR, Walz JS. Tandler C, et al. Among authors: wiesmuller kh. Int J Infect Dis. 2024 Feb;139:69-77. doi: 10.1016/j.ijid.2023.11.009. Epub 2023 Nov 26. Int J Infect Dis. 2024. PMID: 38016500 Free article.
Peptide vaccines and peptide libraries.
Wiesmüller KH, Fleckenstein B, Jung G. Wiesmüller KH, et al. Biol Chem. 2001 Apr;382(4):571-9. doi: 10.1515/BC.2001.070. Biol Chem. 2001. PMID: 11405221 Review.
Peptide libraries in cellular immune recognition.
Uebel S, Wiesmüller KH, Jung G, Tampé R. Uebel S, et al. Among authors: wiesmuller kh. Curr Top Microbiol Immunol. 1999;243:1-21. doi: 10.1007/978-3-642-60142-2_1. Curr Top Microbiol Immunol. 1999. PMID: 10453635 Review. No abstract available.
Anti-Infective and Anti-Inflammatory Mode of Action of Peptide 19-2.5.
Heinbockel L, Weindl G, Correa W, Brandenburg J, Reiling N, Wiesmüller KH, Schürholz T, Gutsmann T, Martinez de Tejada G, Mauss K, Brandenburg K. Heinbockel L, et al. Among authors: wiesmuller kh. Int J Mol Sci. 2021 Feb 2;22(3):1465. doi: 10.3390/ijms22031465. Int J Mol Sci. 2021. PMID: 33540553 Free PMC article.
Designing a SARS-CoV-2 T-Cell-Inducing Vaccine for High-Risk Patient Groups.
Rammensee HG, Gouttefangeas C, Heidu S, Klein R, Preuß B, Walz JS, Nelde A, Haen SP, Reth M, Yang J, Tabatabai G, Bösmüller H, Hoffmann H, Schindler M, Planz O, Wiesmüller KH, Löffler MW. Rammensee HG, et al. Among authors: wiesmuller kh. Vaccines (Basel). 2021 Apr 24;9(5):428. doi: 10.3390/vaccines9050428. Vaccines (Basel). 2021. PMID: 33923363 Free PMC article.
Lipobiotin-capture magnetic bead assay for isolation, enrichment and detection of Mycobacterium tuberculosis from saliva.
Hansen J, Kolbe K, König IR, Scherließ R, Hellfritzsch M, Malm S, Müller-Loennies S, Zallet J, Hillemann D, Wiesmüller KH, Herzmann C, Brandenburg J, Reiling N. Hansen J, et al. Among authors: wiesmuller kh. PLoS One. 2022 Jul 15;17(7):e0265554. doi: 10.1371/journal.pone.0265554. eCollection 2022. PLoS One. 2022. PMID: 35839162 Free PMC article.
173 results